Free. Unsubscribe any time.
ANI PHARMACEUTICALS INC (ANIP)
ANI PHARMACEUTICALS INC filed 43 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 8 reporting owners, covering 46 transactions and 77,506 shares. None carries the SEC's AFF10B5ONE flag; all 43 name a plan in a footnote. 16 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-16, came 2 days after the one before it (2026-09-14) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 5,400 shares, 4,900 more than the 500 in the filing before it.
- Its 43 plan statements rank 129th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 43 filings on file run from 2025-01-13 to 2026-09-16, and state 10 plan adoption dates, from 2024-08-23 to 2026-06-12.
Trades in ANI PHARMACEUTICALS INC 46
- Cook Meredith — 2025-01-13 · S · 400 shares
- Cook Meredith — 2025-02-13 · S · 400 shares
- Davis Krista — 2025-02-21 · S · 1,000 shares
- Davis Krista — 2025-03-07 · S · 1,000 shares
- Cook Meredith — 2025-03-13 · S · 400 shares
- Davis Krista — 2025-03-19 · S · 1,866 shares
- Cook Meredith — 2025-04-14 · S · 400 shares
- Shanmugam Muthusamy — 2025-05-09 · S · 700 shares
- Cook Meredith — 2025-05-13 · S · 400 shares
- Cook Meredith — 2025-06-13 · S · 400 shares
- Cook Meredith — 2025-07-14 · S · 400 shares
- Cook Meredith — 2025-08-13 · S · 400 shares
Adoption dates in ANI PHARMACEUTICALS INC 10
- 2024-08-23 — stated in 4 filings
- 2024-09-17 — stated in 12 filings
- 2024-09-18 — stated in 1 filing
- 2025-06-16 — stated in 5 filings
- 2025-09-15 — stated in 9 filings
- 2025-09-18 — stated in 3 filings
- 2026-03-06 — stated in 5 filings
- 2026-03-09 — stated in 1 filing
- 2026-05-26 — stated in 2 filings
- 2026-06-12 — stated in 1 filing
Results prints in ANI PHARMACEUTICALS INC 16
- 2025-05-09
- 2025-05-20
- 2025-06-04
- 2025-07-23
- 2025-08-08
- 2025-09-08
- 2025-11-07
- 2025-11-10
- 2026-01-12
- 2026-02-27
- 2026-05-08
- 2026-08-07
Trades before a print in ANI PHARMACEUTICALS INC 3
- 0 days before the 2025-01-13 print — 2025-01-13 · S · Cook Meredith · 400 shares
- 0 days before the 2025-05-09 print — 2025-05-09 · S · Shanmugam Muthusamy · 700 shares
- 4 days before the 2025-03-11 print — 2025-03-07 · S · Davis Krista · 1,000 shares
- 7 days before the 2025-02-28 print — 2025-02-21 · S · Davis Krista · 1,000 shares
- 7 days before the 2025-05-20 print — 2025-05-13 · S · Cook Meredith · 400 shares
- 7 days before the 2026-02-27 print — 2026-02-20 · S · Davis Krista · 1,730 shares
- 7 days before the 2026-02-27 print — 2026-02-20 · S · Mutz Christopher · 5,323 shares
- 8 days before the 2026-02-27 print — 2026-02-19 · S · Davis Krista · 2,084 shares
- 9 days before the 2025-07-23 print — 2025-07-14 · S · Cook Meredith · 400 shares
- 9 days before the 2026-08-07 print — 2026-07-29 · S · CAREY STEPHEN P. · 2,850 shares
- 14 days before the 2026-02-27 print — 2026-02-13 · S · Cook Meredith · 500 shares
- 15 days before the 2025-02-28 print — 2025-02-13 · S · Cook Meredith · 400 shares
Interval to ANI PHARMACEUTICALS INC’s next reported results date
How the interval and sources are counted →
- 3within 5 days
- 10within 10 days
- 0shortest, days
- 6no later print
- Cook Meredith 2025-01-13 · S · 0 days before the 2025-01-13 print · SR. VP, GENERAL COUNSEL & SEC.
- Davis Krista 2025-02-21 · S · 7 days before the 2025-02-28 print · SVP, CHIEF HR OFFICER
- Davis Krista 2025-03-07 · S · 4 days before the 2025-03-11 print · SVP, CHIEF HR OFFICER
- Shanmugam Muthusamy 2025-05-09 · S · 0 days before the 2025-05-09 print · HEAD OF R&D, COO-NOVITIUM OPS
- Cook Meredith 2025-05-13 · S · 7 days before the 2025-05-20 print · SR. VP, GENERAL COUNSEL & SEC.
- Cook Meredith 2025-07-14 · S · 9 days before the 2025-07-23 print · SR. VP, GENERAL COUNSEL & SEC.
- Davis Krista 2026-02-19 · S · 8 days before the 2026-02-27 print · SVP, CHIEF HR OFFICER
- Davis Krista 2026-02-20 · S · 7 days before the 2026-02-27 print · SVP, CHIEF HR OFFICER
- Mutz Christopher 2026-02-20 · S · 7 days before the 2026-02-27 print · HEAD OF RARE DISEASE
- CAREY STEPHEN P. 2026-07-29 · S · 9 days before the 2026-08-07 print · SVP & CFO
Adoption dates ANI PHARMACEUTICALS INC states
- 2024-08-23 in 4 filings
- 2024-09-17 in 12 filings
- 2024-09-18 in 1 filing
- 2025-06-16 in 5 filings
- 2025-09-15 in 9 filings
- 2025-09-18 in 3 filings
- 2026-03-06 in 5 filings
- 2026-03-09 in 1 filing
- 2026-05-26 in 2 filings
- 2026-06-12 in 1 filing
Filing text: “10b5-1 trading plan adopted by the reporting person on March 9, 2026”
Reported results dates on file
- 2025-01-13
- 2025-02-05
- 2025-02-28
- 2025-03-11
- 2025-05-09
- 2025-05-20
- 2025-06-04
- 2025-07-23
- 2025-08-08
- 2025-09-08
- 2025-11-07
- 2025-11-10
- 2026-01-12
- 2026-02-27
- 2026-05-08
- 2026-08-07
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.